China Mecobalamin Market Investigation Report, 2018-2022 - Indications, Sales, Competition, Manufacturers, Prices, Market Dynamics & Future Prospects

News provided by

Jan 07, 2019, 18:30 ET

DUBLIN, Jan. 7, 2019 /PRNewswire/ --

The "Investigation Report on China's Mecobalamin Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Mecobalamin is a peripheral nerve repair agent. Mecobalamin tablets are used to treat peripheral neuropathy and diseases caused by vitamin B12 deficiency by repairing damaged nerves, relieving pain and numbness, and alleviating sensory disturbances and movement abnormalities. Mecobalamin injection can be used to treat megaloblastic anemia.

Developed by Eisai Co., Ltd., Mecobalamin (trade name: Methycobal) was launched in Japan in the mid-1980s and introduced to China in 1996. Since 2003, several Chinese pharmaceutical companies have launched generic Mecobalamin products. Mecobalamin has been developing rapidly since it entered China, with its annual sales value increasing from less than CNY 200 million in 2005 to about CNY 609 million in 2017.

There is a huge demand for Mecobalamin in China. China's Mecobalamin market is dominated by Eisai China Inc., Eisai Co., Ltd., Jiangsu Sihuan Biopharmaceutical Co., Ltd., Nanjing Hailing Pharmaceutical Co., Ltd., North China Pharmaceutical Company Ltd., etc. In 2017, the market share by sales value of Eisai Co., Ltd. and its subsidiary Eisai China Inc. totalled about 70%.

It is expected that as lifestyle changes and the population ages, and the incidences of peripheral neuropathy and megaloblastic anemia gradually increases, Mecobalamin will still have some growth potential in China.

Topics Covered:

Indications for Mecobalamin
Sales of Mecobalamin in China
Competition on China's Mecobalamin market
Major Mecobalamin manufacturers in China
Prices of Mecobalamin in China from 2017 to 2018
Major factors influencing the development of China's Mecobalamin market
Prospect of China's Mecobalamin market from 2018 to 2022

Key Topics Covered:

1 Relevant Concepts of Mecobalamin
1.1 Indications for Mecobalamin
1.2 Development of Mecobalamin in China
1.3 Governmental Approval of Mecobalamin in China

2 Sales of Mecobalamin in China, 2013-2017
2.1 Sales Value of Mecobalamin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Mecobalamin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Mecobalamin by Dosage Form in China, 2013-2017
2.3.1 Sales of Mecobalamin Tablets in China
2.3.2 Sales of Mecobalamin Capsules in China
2.3.3 Sales of Mecobalamin Injections in China

3 Analysis of Major Mecobalamin Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Mecobalamin Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Eisai China Inc.
3.2.1 Enterprise Profiles
3.2.2 Sales of Eisai China Inc.'s Mecobalamin
3.3 Eisai Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Eisai Co., Ltd.'s Mecobalamin in China
3.4 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin in China
3.5 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
3.6 North China Pharmaceutical Company Ltd.

4 Prices of Mecobalamin in China, 2017-2018
4.1 Eisai China Inc. (Methycobal)
4.2 Eisai Co., Ltd. (Methycobal)
4.3 Jiangsu Sihuan Biopharmaceutical Co., Ltd. (Zhuohe)
4.4 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. (Qixin)
4.5 North China Pharmaceutical Company Ltd. (Yishenbao)

5 Prospect of China's Mecobalamin Market, 2018-2022
5.1 Major Factors Influencing Development of China's Mecobalamin Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

For more information about this report visit https://www.researchandmarkets.com/research/nxjcgk/china_mecobalamin?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets